Some 30 million euro will be used by the company specialized in copper and copper alloy products for work capital financing as part of a larger balance sheet restructuring and the rest will be allocated for financing energy efficiency measures and increasing capacity for higher value products, EBRD said in a statement.
The investment aims to help Sofia Med shift production towards higher value-added products like high performance alloys and industrial rolled products.
Sofia Med, a leading Bulgarian copper, titanium zinc and brass processor, is a wholly-owned subsidiary of Greek metal processing company Halcor. As many as 95% of Sofia Med’s production is exported to Western and Eastern Europe.
($=0.7846 euro)